RIV Capital Inc (RIV.CX)
0.12
0.00 (0.00%)
CAD |
CNSX |
May 08, 14:35
RIV Capital Debt to Equity Ratio: 1.119 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.119 |
| June 30, 2023 | 1.037 |
| March 31, 2023 | 0.8945 |
| December 31, 2022 | 0.6868 |
| September 30, 2022 | 0.6019 |
| June 30, 2022 | 0.4838 |
| March 31, 2022 | 0.3037 |
| December 31, 2021 | 0.2804 |
| September 30, 2021 | 0.2696 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
1.119
Maximum
Sep 2023
0.3154
Average
0.1348
Median
Debt to Equity Ratio Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | 0.0443 |
| Nova Mentis Life Science Corp | 0.00 |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | -0.5227 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 340.84M |
| Total Liabilities (Quarterly) | 215.27M |
| Shareholders Equity (Quarterly) | 125.57M |
| Current Ratio | 18.40 |
| Net Debt Paydown Yield | -17.01% |